TABLE 1.
1. | Enhancing efficacy while reducing unwanted systemic side effects |
2. | Choosing the correct islet antigen |
3. | Choosing the right dose of antigen |
4. | Choosing optimal time for intervention = identifying ideal target group (pre-diabetic, recent onset) |